Table 3 Information of potential targets and signaling pathways
ID | Pathway | P value | Counts |
|---|---|---|---|
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.12E-25 | 24 |
hsa05160 | Hepatitis C | 7.08E-18 | 22 |
hsa05418 | Fluid shear stress and atherosclerosis | 1.16E-17 | 21 |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.70E-17 | 23 |
hsa05222 | Small cell lung cancer | 5.79E-16 | 17 |
hsa05162 | Measles | 2.88E-15 | 19 |
hsa04657 | IL-17 signaling pathway | 1.75E-14 | 16 |
hsa05163 | Human cytomegalovirus infection | 2.20E-14 | 22 |
hsa04932 | Non-alcoholic fatty liver disease (NAFLD) | 1.72E-13 | 18 |
hsa05145 | Toxoplasmosis | 3.04E-13 | 16 |
hsa05161 | Hepatitis B | 7.49E-13 | 18 |
hsa05142 | Chagas disease (American trypanosomiasis) | 1.15E-12 | 15 |
hsa05210 | Colorectal cancer | 1.63E-12 | 14 |
hsa05164 | Influenza A | 1.73E-12 | 18 |
hsa05169 | Epstein-Barr virus infection | 3.02E-12 | 19 |
hsa04066 | HIF-1 signaling pathway | 3.13E-12 | 15 |
hsa05212 | Pancreatic cancer | 5.57E-12 | 13 |
hsa04659 | Th17 cell differentiation | 3.54E-11 | 14 |
hsa05215 | Prostate cancer | 1.38E-10 | 13 |
hsa04931 | Insulin resistance | 5.44E-10 | 13 |